2003
DOI: 10.1002/14651858.cd004000
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

Abstract: Children fulfilling the diagnostic criteria for Kawasaki disease should be treated with IVIG (2 gm/kg single dose) within 10 days of onset of symptoms.

Search citation statements

Order By: Relevance

Paper Sections

Select...
231
32
22
2

Citation Types

2
147
0
13

Year Published

Range
2000
2000
2026
2026

Publication Types

Select...
212
48
19
3

Relationship

1
281

Authors

Journals

citations

Cited by 282 publications

(162 citation statements)
references

References 53 publications

2
147
0
13
Order By: Relevance
How this paper cites the one you are viewing
“…Among our patient cohort, the CAL complication rate ≤ 30 days of illness in the dKD group was not significantly different from that of the tKD group who had received initial IVIG therapy (9.9 % vs. 7.6 %). In addition, these rates were comparable to those seen in the recent, nationwide surveys in Japan (10.0 % in 2007–2008 and 8.5 % in 2009–2010) [ 11 , 12 ], and lower than those seen in 20–40 % of the historical cohort that received aspirin alone [ 13 , 14 ]. These findings partially support the recommendations of the Japanese rather than American guidelines for KD management; the former state that IVIG therapy is not definitely indicated for spontaneously defervesced KD because of the lesser severity of the disease [ 1 , 2 ].…”
Section: Discussion
supporting
confidence: 80%